Drug Trial Radar · NCT02836574
A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease
Last checked: Nov 20, 2026Latest source record: Aug 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
83
Actual
Start
Sep 2016
Primary completion
Dec 2023
Study completion Dec 2023
Sponsor
- Lead sponsor
- ProkidneyIndustry
- Sponsor type
- Industry
- Collaborators
- CTI Clinical Trial and Consulting Services
- First posted
- Jul 19, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 30 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To assess the safety and efficacy of up to two REACT injections given 6 months (+4 weeks) apart and delivered into the biopsied kidney using a percutaneous approach in participants with Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD).
Conditions
- Type 2 Diabetes Mellitus
- Chronic Kidney Disease
Interventions
Renal Autologous Cell Therapy (REACT)Biological
Autologous selected renal cells (SRC).
Renal BiopsyProcedure
a procedure in which a small sample of kidney tissue is removed
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Renal FunctionTime frame: Through 24 months following last REACT injection for active arm and at least 12 months following last REACT injection for the deferred arm
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
University of Arizona
Tucson, Arizona
Kidney Associates of Colorado
Denver, Colorado
Yale Univeristy
New Haven, Connecticut
University of Florida
Gainesville, Florida
Boise Kidney and Hypertension Institute
Meridian, Idaho
University of Chicago Medical Center
Chicago, Illinois
University of Louisville
Louisville, Kentucky
Renal Associates of Baton Rouge
Baton Rouge, Louisiana
University of Michigan
Ann Arbor, Michigan
Paragon Health
Kalamazoo, Michigan
Nephrology & Hypertension Associates
Tupelo, Mississippi
Mt. Sinai Hospital
New York, New York
University of North Carolina- Chapel Hill
Chapel Hill, North Carolina
Lehigh Valley Health Network
Allentown, Pennsylvania
Vanderbilt University
Nashville, Tennessee
University of Wisconsin-Madison
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.